Attached files
| file | filename |
|---|---|
| 10-K/A - FORM 10-K AMENDMENT - Fibrocell Science, Inc. | d338841d10ka.htm |
| EX-31.1 - SECTION 302 CEO CERTIFICATION - Fibrocell Science, Inc. | d338841dex311.htm |
| EX-32.1 - SECTION 906 CEO CERTIFICATION - Fibrocell Science, Inc. | d338841dex321.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - Fibrocell Science, Inc. | d338841dex312.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO SECTION 1350 OF
CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE
For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Declan Daly, Chief Financial Officer of Fibrocell Science, Inc. (the “Company”), hereby certifies that:
| i. | the Annual Report on Form 10-K/A of the Company for the year ended December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Commission Act of 1934; and |
| ii. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: April 23, 2012
| By: | /s/ Declan Daly | |
| Declan Daly | ||
| Chief Financial Officer | ||
| Fibrocell Science, Inc. |
A signed original of this written statement required by Section 906 has been provided to Fibrocell Science, Inc. and will be retained by Fibrocell Science, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
19